Search Results - Liping Liang

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Impedance analysis and optimization research of power distribution network

    Impedance analysis and optimization research of power distribution network by Cheng Hong, Zhiqiang Li, Wu Guan, Liping Liang

    Published 2025-06-01

    Abstract The impedance characteristics of Power Distribution Networks (PDN) at the circuit level have always been critical in high-speed circuit design. However, to address power integrity issues caused by the reduction in chip feature sizes and the rapid increase in integrated circuit transistors c...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Multi-omics derivation of a core gene signature for predicting therapeutic response and characterizing immune dysregulation in inflammatory bowel disease

    Multi-omics derivation of a core gene signature for predicting therapeutic response and characterizing immune dysregulation in inflammatory bowel disease by Mingming Wang, Liping Liang, Zibo Tang, Jimin Han, Lele Wu, Le Liu, Le Liu, Ye Chen, Ye Chen

    Published 2025-07-01

    BackgroundInflammatory bowel disease (IBD) presents unpredictable therapeutic responses and complex immune dysregulation. Current precision medicine approaches lack robust molecular tools integrating transcriptomic signatures with immune dynamics for personalized treatment guidance.MethodsWe perform...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice

    An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice by Xianxin Qiu, Liping Liang, Lingchao Chen, Pengjie Hong, Wanzun Lin, Jiabing Liu, Zhirui Zhou, Wenjia Zhu, Tianqi Wu, Mingyuan Pan, Yihua Zhong, Jing Gao, Zhiyong Qin, Yang Wang

    Published 2025-07-01

    ABSTRACT Purpose There is ongoing debate regarding the therapeutic approach and prognosis for IDH‐mutant grade 4 astrocytoma, a newly defined subtype of diffuse glioma in the 2021 WHO classification system for central nervous system tumors (WHO CNS 5). The aim of this study was to explore the clinic...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: